2022
Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon
Rima M, Oueslati S, Dabos L, Daaboul D, Mallat H, Raad E, Achkar M, Mawlawi O, Bernabeu S, Bonnin R, Girlich D, Osman M, Hamze M, Naas T. Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon. Antibiotics 2022, 11: 1295. PMID: 36289953, PMCID: PMC9598570, DOI: 10.3390/antibiotics11101295.Peer-Reviewed Original ResearchCarbapenem-resistant Gram-negative bacilliCarbapenem resistanceGram-negative bacilliHealth care centersCare centerEpidemiological surveyDiscordant resultsCarba NP testHealth issuesOXA-162PCR sequencingNP testHospitalPrevalenceMolecular mechanismsNovel variantsIsolatesImmunochromatographic assayRegistration systemResistance spreadOXABacilliCarbapenemsGenes
2019
Recent trends in the epidemiology, diagnosis, treatment, and mechanisms of resistance in clinical Aspergillus species: A general review with a special focus on the Middle Eastern and North African region
Zakaria A, Osman M, Dabboussi F, Rafei R, Mallat H, Papon N, Bouchara J, Hamze M. Recent trends in the epidemiology, diagnosis, treatment, and mechanisms of resistance in clinical Aspergillus species: A general review with a special focus on the Middle Eastern and North African region. Journal Of Infection And Public Health 2019, 13: 1-10. PMID: 31672427, DOI: 10.1016/j.jiph.2019.08.007.Peer-Reviewed Original ResearchConceptsInfectious disease specialistsSuccessful treatment outcomeIndividual patient therapyAntifungal susceptibility patternsAvailable diagnostic toolsAspergillus sppDisease specialistsAspergillus infectionMechanisms of resistanceTreatment outcomesSusceptibility patternsEarly diagnosisPatient therapyHealth workforceFungal infectionsEpidemiological surveillanceHealth issuesAntifungal resistance mechanismsHealth careAntifungal resistanceAspergillosisPatientsDiagnostic toolInfectionEpidemiology